Researchers continue to study the antioxidant, publishing promising results annually
It carries a low risk of hypoglycemia [00:01:30] so it's safe to continue during steroid tapers
Its effectiveness is attributed to its unique mechanism of action, which imitates the functions of the endogenous GLP-1 hormone , an incretin hormone that plays an instrumental role in regulating glucose metabolism
JourneyLite prioritizes: Patient safety Realistic expectations Long-term success, not short-term fixes Ready to Explore Oral Weight Loss Options
Retrieved from Saito, M., Matsushita, M., Yoneshiro, T., et al
The glucagon arm distinguishes it from tirzepatide (GIP/GLP-1 dual) and semaglutide (GLP-1 mono), and is the mechanistic basis for the hepatic fat-oxidation signal, including the reported 86% liver-fat reduction cited in 2026 secondary summaries [1][2] [unverified]